Ledger.Open graph →
SEC Form D · filed December 30, 2022

Halia Therapeutics, Inc

Offering
$50.0M
Sold
$12.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Salt Lake City, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jeffrey Burton · Salt Lake City, UTExecJared Bearss · Salt Lake City, UTDirectorJohn S. Kauwe · Salt Lake City, UTDirectorDavid Bearss · Salt Lake City, UTExec · DirectorJim S. Savas · Salt Lake City, UTDirectorJeffrey Burton · Salt Lake City, UTExecJared Bearss · Salt Lake City, UTDirectorDavid Bearss · West Valley City, UTExec · DirectorJohn S. Kauwe · Salt Lake City, UTDirectorJim S. Savas · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗